2015
DOI: 10.1038/ncomms7825
|View full text |Cite
|
Sign up to set email alerts
|

New basal cell carcinoma susceptibility loci

Abstract: In an ongoing screen for DNA sequence variants that confer risk of cutaneous basal cell carcinoma (BCC), we conduct a genome-wide association study (GWAS) of 24,988,228 SNPs and small indels detected through whole-genome sequencing of 2,636 Icelanders and imputed into 4,572 BCC patients and 266,358 controls. Here we show the discovery of four new BCC susceptibility loci: 2p24 MYCN (rs57244888[C], OR=0.76, P=4.7 × 10−12), 2q33 CASP8-ALS2CR12 (rs13014235[C], OR=1.15, P=1.5 × 10−9), 8q21 ZFHX4 (rs28727938[G], OR=… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
56
0
2

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 62 publications
(60 citation statements)
references
References 68 publications
2
56
0
2
Order By: Relevance
“…SNPs close to CDKN1A, for example, have been associated with electrocardiographic measures (35) and colorectal cancer (36). While the CDKN2A/CDKN2B and CDKN2B-AS1 locus has been found in GWAS of Type 2 Diabetes (37), fasting glucose (38), intracranial aneurysm (39), myocardial infraction (40), coronary heart disease (41) and various cancers, including basal cell carcinoma (42), breast (43) and prostate (44) cancer, and glioma (45). Interestingly, the same allele in CDKN2B that decrease risk of POAG, was found associated with increased risk of glioma.…”
Section: à5mentioning
confidence: 99%
“…SNPs close to CDKN1A, for example, have been associated with electrocardiographic measures (35) and colorectal cancer (36). While the CDKN2A/CDKN2B and CDKN2B-AS1 locus has been found in GWAS of Type 2 Diabetes (37), fasting glucose (38), intracranial aneurysm (39), myocardial infraction (40), coronary heart disease (41) and various cancers, including basal cell carcinoma (42), breast (43) and prostate (44) cancer, and glioma (45). Interestingly, the same allele in CDKN2B that decrease risk of POAG, was found associated with increased risk of glioma.…”
Section: à5mentioning
confidence: 99%
“…Zfh2 is part of a large family of zinc finger homeodomain proteins present in most metazoans (Fig. 3 B and (46)), with the two clearest human orthologs of Zfh2 being ZFHX3 (also known as ATBF1, ATBT, ZNF927) (47-54) and ZFHX4 (55-57). Human ZFHX3 and ZFHX4 also encode large ~400 kDa proteins containing 23 zinc fingers and 4 homeodomains (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…ZFHX3 is involved in neural and epithelial development (47-50), implicated by GWAS in atrial fibrillation (51) and has roles in multiple types of cancer (52-54). Similarly, ZFHX4 is involved in epithelial and glial cancers (55, 56), and neuronal development (57). However, neither Zfh2 nor its human orthologs ZFHX3 and ZFHX4 had previously been shown to regulate immune gene transcription or gas sensing.…”
Section: Resultsmentioning
confidence: 99%
“…GWASs have also shown associations with basal cell and melanoma skin cancer risk (Barrett et al, 2011; Bishop et al, 2009; Brown et al, 2008; Falchi et al, 2009; Gudbjartsson et al, 2008; Law et al, 2015; Macgregor et al, 2011; Stacey et al, 2008, 2009, 2011, 2015). In the case of melanoma these include genes involved in melanocyte development and telomere maintenance.…”
Section: Gwas Highlights In Dermatologymentioning
confidence: 99%